Martin L Breitman, Deceased

Title: Martin L Breitman: A Legacy in Receptor Tyrosine Kinase Research

Introduction

Martin L Breitman was a notable inventor whose contributions to the field of molecular biology have left a lasting impact. He was based in Willowdale, CA, and is remembered for his innovative work in receptor tyrosine kinases. His research has paved the way for advancements in understanding cellular signaling mechanisms.

Latest Patents

Breitman held a patent for a novel receptor tyrosine kinase protein and its isoforms, which are expressed in cells of the endothelial lineage. The patent, titled "Nucleic acid encoding tek receptor tyrosine kinase," discloses DNA segments encoding the novel protein and its isoforms. Additionally, it outlines methods for identifying ligands capable of binding to the receptor protein, as well as techniques for screening agonist or antagonist substances that interact with the protein and a ligand.

Career Highlights

Throughout his career, Martin L Breitman was associated with the Mount Sinai Hospital Corporation, where he conducted significant research. His work has contributed to the understanding of receptor tyrosine kinases, which play crucial roles in various biological processes.

Collaborations

Breitman collaborated with esteemed colleagues such as Janet Rossant and Daniel J Dumont, further enhancing the quality and impact of his research.

Conclusion

Martin L Breitman's contributions to receptor tyrosine kinase research and his innovative patent have solidified his legacy in the scientific community. His work continues to influence ongoing research in molecular biology and related fields.